Short answer
CVRx, Inc. (CVRX) filed an 8-K current report with the SEC on September 21, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). John Landry appointed CFO effective after CVRx files its September 30, 2026 Form 10-Q.
CVRx, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- John Landry appointed CFO effective after CVRx files its September 30, 2026 Form 10-Q
- Succeeds Jared Oasheim, whose previously announced resignation awaits successor transition
- Base salary $500,000 with target cash incentive of 50%, prorated for fiscal 2026
- Initial equity award equals 0.80% of outstanding common shares, split 75% options and 25% RSUs
- Medical-technology finance background may support leadership continuity during CFO transition
Item EX-99.1 · Exhibit EX-99.1
- John Landry appointed CFO, succeeding Jared Oasheim after his previously announced resignation
- Landry joins October 12, 2026 and assumes CFO duties after CVRx files its September 30, 2026 Form 10-Q
- Two decades of medtech finance experience, including IPO leadership and capital raises at Nyxoah and Vapotherm
- Appointment signals focus on operating discipline, expense management, capital markets execution, and Barostim commercial scaling
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CVRx, Inc. 8-K filings
Get the next CVRX 8-K as it lands
Follow CVRX for push alerts, or ask the research agent what this filing means.